Bookbot

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders

Parameter

  • 139 Seiten
  • 5 Lesestunden

Mehr zum Buch

Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.

Buchkauf

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders, Paolo Pozzilli, Carlo Pozzilli, J.-F. Kapp

Sprache
Erscheinungsdatum
2001
Einband
(Hardcover),
Buchzustand
Gebraucht - Gut
Preis
12,99 €inkl. MwSt.

Lieferung

  • Gratis Versand ab 14,99 € in ganz Deutschland! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders
Sprache
Englisch
Verlag
Springer
Erscheinungsdatum
2001
Einband
Hardcover
Seitenzahl
139
ISBN10
3540414797
ISBN13
9783540414797
Reihe
Beschreibung
Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.